Publications & Presentations

  • || CAT-248 (Engineered NK cells expressing CD70 CAR, IL15, and TGFβ DNR) demonstrates in vivo expansion, tumor infiltration, and durable regression of multiple CD70-expressing xenograft tumors

    SITC 2023 Poster Presentation

      Read More
  • || Spinner flask modelling of wave-style bioreactors enables suspension-phase cell culture process development of allogeneic CAR-NK cell therapies

    ASGCT 2023 Poster Presentation

      Read More
  • || CAT-248, an Allogeneic CD70-Directed CAR-NK Cell Therapy, Effectively Controls CD70-Positive Tumor Xenografts

    AACR 2023 Annual Meeting Poster Presentation

      Read More
  • || CAT-179, an allogeneic NK cell product expressing HER2-CAR, IL-15 and TGFβ dominant negative receptor, durably regresses HER2-expressing xenograft tumors in mic

    AACR 2023 Annual Meeting Poster Presentation

      Read More
  • || Selection of Engineered K562 Feeder Cell Clone for CAR-NK Drug Product Manufacturing Process

    Innate Killer Summit 2023 Poster Presentation

      Read More
  • || Allogeneic natural killer cells engineered to express HER2-directed CAR, Interleukin 15, and TGF-beta dominant negative receptor effectively control HER2+tumors

    SITC 2022 Poster presentation

      Read More
  • || Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies

    SITC 2022 Poster presentation

      Read More
  • || A Synthetic Biology Approach to Address the Immunosuppressive Tumor Microenvironment: Novel TGF-β Switch Receptors Convert Inhibitory Signals into Enhanced NK Cell Activity

    ASGCT 2022 Poster presentation

      Read More
  • || Engineered Allogeneic Car-Natural Killer Cells Resist Tumor Microenvironment Immuno-Suppression by Expression of a TGFBR2 Dominant Negative Receptor

    ASGCT 2022 Poster Presentation

      Read More
  • || Allogeneic Natural Killer Cells Engineered to Express HER2 CAR, Interleukin 15, and TGF-Beta Dominant Negative Receptor Effectively Control HER2+ Tumors

    AACR 2022 Poster Presentation

      Read More
  • || Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies

    ASH 2021 Poster Presentation

      Read More
  • || Cryopreservation of Natural Killer and anti-CD19 Chimeric Antigen Receptor Natural Killer Cells

    BMES 2021 Poster Presentation

      Read More